| 複写 |  |
|---|---|
| 関連リンク |  |
| 出版者サイト |  |
文献
J-GLOBAL ID：200902235607905036
整理番号：09A0411134 目でみるページ-症例報告 拡張相肥大型心筋症:End-stage Hypertrophic Cardiomyopathy
クリップ引用文献 (22件)
- Maron BJ: Hypertrophic cardiomyopathy. Lancet 350: 127-133.1997
- 室 愛子, 古賀義則, 西 宏文, 他: 肥大型心筋症の予後予測因子としての左室流出路狭窄の重要性. 心臓32: 404-41L 2000
- 河合忠一, 他: 特発性心筋症の予後調査, 厚生省特定疾患特発性心筋症調査研究班研究昭和57年度報告集.63-66, 1983
- 宮本哲哉, 古賀義則; 肥大型心筋症とは. Heart View 5: 838-842, 2001
- 古賀義則: 心筋肥大の発現と進行. 症例に学ぶ肥大型心筋症. 戸嶋裕徳編, 久留米, 久留米大学第三内科, 23-32, 1994
- Koga Y, Miyamoto T, Ohtsuki T, et al Natural history of hypertrophic cardiomyopathy: Japanese experience. J Cardiol 37 (Suppl 1): 147-154, 2001
- 足達 教: 拡張相肥大型心筋症--収縮不全--. 症例に学ぶ肥大型心筋症, 戸嶋裕徳編, 久留米, 久留米大学第三内科, 170-177, 1994
- Spirito P, Maron BJ, Bonow RO Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy. Am J Cardiol 60: 123-129, 1987
- Fujiwara H, Onodera T, Tanaka M, et al: Progression from hypertrophic obstructive cardiomyopathy to typical dilated cardiomyopathy-like features in the end stage. Jpn Circ J 48: 1210-1214, 1984
- Harris KM, Spirito P, Maron MS, et al: Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 114: 216-225, 2006
- Yacoub MH, Olivotto I, Cecchi F:‘End-stage’ hypertrophic cardiomyopathy: from mystery to model. Nat Clin Pract Cardiovasc Med 4: 232-233, 2007
- 大森浩二: 拡張相肥大型心筋症. 日本臨牀別冊新領域別症候群シリーズ.6〔循環器症候群 (第2版) 皿〕: 30-34, 2007
- Iida K, Yutani C, Imakita M, et al: Comparison of percentage area of myocardial fibrosis and disarray in patients with classical form and dilated phase of hypertrophic cardiomyopathy. J Cardiol 32: 173-180, 1998
- 北浦 泰, 伊藤隆英, 寺本文生: 心筋症の最前線, 拡張相肥大型心筋症を識る. Heart View 12: 922-927, 2008
- Maron BJ, Wolfson JK, Epstein SE, et al: Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 8: 545-557, 1986
- 木村彰方: 心筋症の最前線. 遺伝子変異. Heart View 12: 975-981, 2008
- Fujino N, Shimizu M, Ino H, et al: A novel mutation Lys273Glu in the cardiac troponin T gene shows high degree of penetrance and transition from hypertrophic to dilated cardiomyopathy. Am J Cardiol 89: 29-33, 2002
- Ino T, Nishimoto K, Okubo M, et al: Apoptosis as a possible cause of wall thinning in end-stage hypertrophic cardiomyopathy. Am J Cardiol 79: 1137-1141, 1997
- Yutani C, Imakita M, Ishibashi-Ueda H, et al: Histopathological study of hypertrophic cardiomyopathy with progression to left ventricular dilatation. Acta Pathol Jpn 37: 1041-1052, 1987
- Maron BJ, Towbin JA, Thiene G, et al: Contemporary definitions and classification of the cardiomyopathies an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulationl113: 1807-1816, 2006
前のページに戻る
